Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?
作者信息
Pullar T
机构信息
Department of Medicine, University of Leeds.
出版信息
Br J Clin Pharmacol. 1990 Oct;30(4):501-10. doi: 10.1111/j.1365-2125.1990.tb03807.x.
Abstract
摘要
相似文献
1
Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?
Br J Clin Pharmacol. 1990 Oct;30(4):501-10. doi: 10.1111/j.1365-2125.1990.tb03807.x.
2
The early use of disease-modifying antirheumatic drugs in rheumatoid arthritis.
Arthritis Rheum. 1990 Mar;33(3):451. doi: 10.1002/art.1780330326.
3
[The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis].
Clin Ter. 1993 Jan;142(1):3-18.
4
[Progress on therapy of collagen diseases and rheumatoid arthritis].
Nihon Naika Gakkai Zasshi. 1993 Mar 10;82(3):386-9.
5
[Guidelines for planning the therapy of rheumatoid arthritis].
Recenti Prog Med. 1986 Jun;77(6):289-300.
6
Drugs for rheumatoid arthritis.
Med Lett Drugs Ther. 1994 Nov 11;36(935):101-6.
7
Drugs for rheumatoid arthritis.
Med Lett Drugs Ther. 1987 Feb 27;29(734):21-4.
8
Treatment of rheumatoid arthritis: our experience.
Clin Exp Rheumatol. 1989 Sep-Oct;7 Suppl 3:S187-93.
9
Disease-modifying drug therapy in rheumatoid arthritis.
Clin Ther. 1986;9(1):2-7.
10
[Treatment of chronic polyarthritis].
Med Monatsschr Pharm. 1989 Dec;12(12):388-9.
引用本文的文献
1
A Systematic Review Comparing Experimental Design of Animal and Human Methotrexate Efficacy Studies for Rheumatoid Arthritis: Lessons for the Translational Value of Animal Studies.
Animals (Basel). 2020 Jun 17;10(6):1047. doi: 10.3390/ani10061047.
2
Effects of stanozolol on normal and IL-1β-stimulated equine chondrocytes in vitro.
BMC Vet Res. 2018 Mar 20;14(1):103. doi: 10.1186/s12917-018-1426-z.
3
Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects.
Br J Clin Pharmacol. 1995 Aug;40(2):127-33. doi: 10.1111/j.1365-2125.1995.tb05768.x.
4
A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.
Drug Saf. 1994 Jul;11(1):21-36. doi: 10.2165/00002018-199411010-00004.
5
Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.
Drugs. 1995 Jul;50(1):137-56. doi: 10.2165/00003495-199550010-00009.
本文引用的文献
1
Salazopyrin in the Treatment of Rheumatoid Arthritis.
Ann Rheum Dis. 1949 Sep;8(3):226-31. doi: 10.1136/ard.8.3.226.
2
Gold Treatment in Rheumatoid Arthritis.
Ann Rheum Dis. 1945 Jun;4(4):71-5. doi: 10.1136/ard.4.4.71.
3
Treatment of lupus erythematosus with mepacrine.
Lancet. 1951 Oct 27;2(6687):755-8. doi: 10.1016/s0140-6736(51)91643-1.
4
Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
J Rheumatol. 1988 Dec;15(12):1747-54.
5
Combined therapy of rheumatoid arthritis with gold and chloroquine. I. Evaluation of the therapeutic effect.
Acta Rheumatol Scand. 1963;9:48-55.
6
Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis.
Arthritis Rheum. 1962 Oct;5:502-12. doi: 10.1002/art.1780050507.
7
Chloroquine and rheumatoid arthritis; a short-term controlled trial.
Ann Rheum Dis. 1956 Sep;15(3):251-7. doi: 10.1136/ard.15.3.251.
8
Penicillamine, a new oral therapy for Wilson's disease.
Am J Med. 1956 Oct;21(4):487-95. doi: 10.1016/0002-9343(56)90066-3.
9
Long-term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response.
Br J Clin Pharmacol. 1981 Oct;12(4):579-81. doi: 10.1111/j.1365-2125.1981.tb01268.x.
10
Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.
Arthritis Rheum. 1982 Aug;25(8):923-9. doi: 10.1002/art.1780250803.
Zotero 插件